• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology.

作者信息

Nussbaum Dillon, Wei Chapman, Pakhchanian Haig, Raiker Rahul, Liu Ivan Z, Friedman Adam

机构信息

Department of Dermatology, George Washington University, Washington, District of Columbia.

Department of Medicine, Staten Island University Hospital, Staten Island, New York.

出版信息

JAAD Int. 2022 Jun;7:124-125. doi: 10.1016/j.jdin.2022.03.005. Epub 2022 Mar 17.

DOI:10.1016/j.jdin.2022.03.005
PMID:35313669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8926877/
Abstract
摘要

相似文献

1
Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology.新型冠状病毒肺炎大流行期间玫瑰糠疹新诊断病例数的减少：支持病毒病因学的证据
JAAD Int. 2022 Jun;7:124-125. doi: 10.1016/j.jdin.2022.03.005. Epub 2022 Mar 17.
2
Reply to "Pityriasis rosea during COVID-19 and its pathogenesis".对“新型冠状病毒肺炎期间的玫瑰糠疹及其发病机制”的回复
JAAD Int. 2022 Dec;9:153-154. doi: 10.1016/j.jdin.2022.05.014. Epub 2022 Sep 27.
3
Pityriasis Rosea Induced by COVID-19 Vaccination.新冠疫苗接种诱发的玫瑰糠疹
Eur J Case Rep Intern Med. 2022 Feb 3;9(2):003164. doi: 10.12890/2022_003164. eCollection 2022.
4
Study of role of streptococcal throat infection in pityriasis rosea.链球菌性咽喉感染在玫瑰糠疹中作用的研究。
Indian J Dermatol. 2008;53(4):171-3. doi: 10.4103/0019-5154.44787.
5
Pityriasis rosea during the COVID-19 pandemic: Further support for a viral etiology.新冠疫情期间的玫瑰糠疹：对病毒病因的进一步支持。
JAAD Int. 2022 Dec;9:155. doi: 10.1016/j.jdin.2022.04.011. Epub 2022 Sep 22.
6
Pityriasis rosea: roles of the dermatology nurse.
Dermatol Nurs. 2004 Apr;16(2):130-4; quiz 137.
7
Pityriasis rosea.玫瑰糠疹
Am Fam Physician. 2004 Jan 1;69(1):87-91.
8
Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.新型冠状病毒病信使核糖核酸疫苗接种后出现玫瑰糠疹样皮疹：一例病例报告及文献复习
JAAD Int. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Epub 2022 Feb 9.
9
A Case-Control Study on the Take-Off Sign in Lesional Skin Biopsies of Patients with Pityriasis Rosea.玫瑰糠疹患者皮损皮肤活检中“起飞征”的病例对照研究
Iran J Pathol. 2016 Fall;11(4):416-417.
10
Paraviral exanthems.副病毒性疹病
Expert Rev Anti Infect Ther. 2016 Jun;14(6):601-11. doi: 10.1080/14787210.2016.1184084.

引用本文的文献

1
Reader comments.读者评论。
Proc (Bayl Univ Med Cent). 2022 Oct 12;36(1):140-141. doi: 10.1080/08998280.2022.2132368. eCollection 2023.
2
Reply to "Pityriasis rosea during COVID-19 and its pathogenesis".对“新型冠状病毒肺炎期间的玫瑰糠疹及其发病机制”的回复
JAAD Int. 2022 Dec;9:153-154. doi: 10.1016/j.jdin.2022.05.014. Epub 2022 Sep 27.
3
Pityriasis rosea during COVID-19 and its pathogenesis.新型冠状病毒肺炎期间的玫瑰糠疹及其发病机制。

本文引用的文献

1
Herpes simplex and herpes zoster viruses in COVID-19 patients.COVID-19 患者中的单纯疱疹病毒和带状疱疹病毒。
Ir J Med Sci. 2022 Jun;191(3):1093-1097. doi: 10.1007/s11845-021-02714-z. Epub 2021 Jul 11.
2
Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020.2020年新加坡新冠疫情期间呼吸道病毒感染趋势
JAMA Netw Open. 2021 Jun 1;4(6):e2115973. doi: 10.1001/jamanetworkopen.2021.15973.
3
Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020.
JAAD Int. 2022 Dec;9:159-160. doi: 10.1016/j.jdin.2022.05.015. Epub 2022 Sep 22.
4
Pityriasis rosea during the COVID-19 pandemic: Further support for a viral etiology.新冠疫情期间的玫瑰糠疹：对病毒病因的进一步支持。
JAAD Int. 2022 Dec;9:155. doi: 10.1016/j.jdin.2022.04.011. Epub 2022 Sep 22.
新冠疫情期间流感活动减少——美国、澳大利亚、智利和南非，2020 年。
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1305-1309. doi: 10.15585/mmwr.mm6937a6.
4
Pityriasis rosea--a virus-induced skin disease? An update.
Arch Virol. 2000;145(8):1509-20. doi: 10.1007/s007050070072.